The Asia Pacific Genomics In Cancer Care Market would witness market growth of 16.3% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Genomics In Cancer Care Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $4,046 million by 2031. The Japan market is registering a CAGR of 15.7% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 17% during (2024 - 2031).
Genomic analysis of cancer cells can identify tumor-specific antigens—unique proteins produced by cancer cells do not present in normal cells. These antigens can be targeted for immunotherapy, enabling the development of personalized cancer vaccines and other immune-based therapies designed to enhance the immune system’s ability to recognize and attack cancer cells.
Moreover, genomic profiling of tumors can inform the customization of radiation therapy. By understanding cancer cells’ specific genetic alterations and repair mechanisms, clinicians can tailor radiation doses and treatment schedules to maximize effectiveness while minimizing damage to surrounding healthy tissues. This approach, known as precision radiotherapy, improves treatment outcomes and reduces side effects.
The expansion of the hospital sector in India has resulted in developing new and upgraded healthcare facilities, including those specializing in cancer care. These hospitals are increasingly equipped with state-of-the-art genomic technologies for diagnostics and treatment, thereby driving demand for genomics in cancer care. As per the data published by the National Investment Promotion and Facilitation Agency of India, the hospital industry in India, which accounts for 80% of the entire healthcare industry, is experiencing high investment demand from international and domestic investors. The healthcare industry was expected to rise to $132 billion by 2023.
Free Valuable Insights: The Global Genomics In Cancer Care Market is Predict to reach USD 53.5 Billion by 2031, at a CAGR of 15.7%
Based on Application, the market is segmented into Diagnostics, Personalized Medicine, Drug Discovery & Development, and Research. Based on Product, the market is segmented into Instruments, Consumables, Services. Based on Technology, the market is segmented into PCR, Genome Sequencing, Microarrays, Nuclei Acid Extraction & Purification, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Agilent Technologies, Inc.
- F.Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- GE HealthCare Technologies, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.
Asia Pacific Genomics In Cancer Care Market Report Segmentation
By Application
- Diagnostics
- Personalized Medicine
- Drug Discovery & Development
- Research
By Product
- Instruments
- Consumables
- Services
By Technology
- PCR
- Genome Sequencing
- Microarrays
- Nuclei Acid Extraction & Purification
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Genomics In Cancer Care Market, by Application
1.4.2 Asia Pacific Genomics In Cancer Care Market, by Product
1.4.3 Asia Pacific Genomics In Cancer Care Market, by Technology
1.4.4 Asia Pacific Genomics In Cancer Care Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan – 2023, Jan) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Asia Pacific Genomics In Cancer Care Market by Application
5.1 Asia Pacific Diagnostics Market by Country
5.2 Asia Pacific Personalized Medicine Market by Country
5.3 Asia Pacific Drug Discovery & Development Market by Country
5.4 Asia Pacific Research Market by Country
Chapter 6. Asia Pacific Genomics In Cancer Care Market by Product
6.1 Asia Pacific Instruments Market by Country
6.2 Asia Pacific Consumables Market by Country
6.3 Asia Pacific Services Market by Country
Chapter 7. Asia Pacific Genomics In Cancer Care Market by Technology
7.1 Asia Pacific PCR Market by Country
7.2 Asia Pacific Genome Sequencing Market by Country
7.3 Asia Pacific Microarrays Market by Country
7.4 Asia Pacific Nuclei Acid Extraction & Purification Market by Country
7.5 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Genomics In Cancer Care Market by Country
8.1 China Genomics In Cancer Care Market
8.1.1 China Genomics In Cancer Care Market by Application
8.1.2 China Genomics In Cancer Care Market by Product
8.1.3 China Genomics In Cancer Care Market by Technology
8.2 Japan Genomics In Cancer Care Market
8.2.1 Japan Genomics In Cancer Care Market by Application
8.2.2 Japan Genomics In Cancer Care Market by Product
8.2.3 Japan Genomics In Cancer Care Market by Technology
8.3 India Genomics In Cancer Care Market
8.3.1 India Genomics In Cancer Care Market by Application
8.3.2 India Genomics In Cancer Care Market by Product
8.3.3 India Genomics In Cancer Care Market by Technology
8.4 South Korea Genomics In Cancer Care Market
8.4.1 South Korea Genomics In Cancer Care Market by Application
8.4.2 South Korea Genomics In Cancer Care Market by Product
8.4.3 South Korea Genomics In Cancer Care Market by Technology
8.5 Singapore Genomics In Cancer Care Market
8.5.1 Singapore Genomics In Cancer Care Market by Application
8.5.2 Singapore Genomics In Cancer Care Market by Product
8.5.3 Singapore Genomics In Cancer Care Market by Technology
8.6 Malaysia Genomics In Cancer Care Market
8.6.1 Malaysia Genomics In Cancer Care Market by Application
8.6.2 Malaysia Genomics In Cancer Care Market by Product
8.6.3 Malaysia Genomics In Cancer Care Market by Technology
8.7 Rest of Asia Pacific Genomics In Cancer Care Market
8.7.1 Rest of Asia Pacific Genomics In Cancer Care Market by Application
8.7.2 Rest of Asia Pacific Genomics In Cancer Care Market by Product
8.7.3 Rest of Asia Pacific Genomics In Cancer Care Market by Technology
Chapter 9. Company Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Danaher Corporation (Beckman Coulter, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 GE HealthCare Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Quest Diagnostics Incorporated
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 SWOT Analysis
9.8 Revvity, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Eurofins Scientific SE
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
TABLE 1 Asia Pacific Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Genomics In Cancer Care Market
TABLE 4 Product Launches And Product Expansions– Genomics In Cancer Care Market
TABLE 5 Acquisition and Mergers– Genomics In Cancer Care Market
TABLE 6 Asia Pacific Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 7 Asia Pacific Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 8 Asia Pacific Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 9 Asia Pacific Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 10 Asia Pacific Personalized Medicine Market by Country, 2020 - 2023, USD Million
TABLE 11 Asia Pacific Personalized Medicine Market by Country, 2024 - 2031, USD Million
TABLE 12 Asia Pacific Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 13 Asia Pacific Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 14 Asia Pacific Research Market by Country, 2020 - 2023, USD Million
TABLE 15 Asia Pacific Research Market by Country, 2024 - 2031, USD Million
TABLE 16 Asia Pacific Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 17 Asia Pacific Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 18 Asia Pacific Instruments Market by Country, 2020 - 2023, USD Million
TABLE 19 Asia Pacific Instruments Market by Country, 2024 - 2031, USD Million
TABLE 20 Asia Pacific Consumables Market by Country, 2020 - 2023, USD Million
TABLE 21 Asia Pacific Consumables Market by Country, 2024 - 2031, USD Million
TABLE 22 Asia Pacific Services Market by Country, 2020 - 2023, USD Million
TABLE 23 Asia Pacific Services Market by Country, 2024 - 2031, USD Million
TABLE 24 Asia Pacific Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 25 Asia Pacific Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 26 Asia Pacific PCR Market by Country, 2020 - 2023, USD Million
TABLE 27 Asia Pacific PCR Market by Country, 2024 - 2031, USD Million
TABLE 28 Asia Pacific Genome Sequencing Market by Country, 2020 - 2023, USD Million
TABLE 29 Asia Pacific Genome Sequencing Market by Country, 2024 - 2031, USD Million
TABLE 30 Asia Pacific Microarrays Market by Country, 2020 - 2023, USD Million
TABLE 31 Asia Pacific Microarrays Market by Country, 2024 - 2031, USD Million
TABLE 32 Asia Pacific Nuclei Acid Extraction & Purification Market by Country, 2020 - 2023, USD Million
TABLE 33 Asia Pacific Nuclei Acid Extraction & Purification Market by Country, 2024 - 2031, USD Million
TABLE 34 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 35 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 36 Asia Pacific Genomics In Cancer Care Market by Country, 2020 - 2023, USD Million
TABLE 37 Asia Pacific Genomics In Cancer Care Market by Country, 2024 - 2031, USD Million
TABLE 38 China Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 39 China Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 40 China Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 41 China Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 42 China Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 43 China Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 44 China Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 45 China Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 46 Japan Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 47 Japan Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 48 Japan Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 49 Japan Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 50 Japan Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 51 Japan Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 52 Japan Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 53 Japan Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 54 India Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 55 India Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 56 India Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 57 India Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 58 India Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 59 India Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 60 India Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 61 India Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 62 South Korea Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 63 South Korea Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 64 South Korea Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 65 South Korea Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 66 South Korea Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 67 South Korea Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 68 South Korea Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 69 South Korea Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 70 Singapore Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 71 Singapore Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 72 Singapore Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 73 Singapore Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 74 Singapore Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 75 Singapore Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 76 Singapore Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 77 Singapore Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 78 Malaysia Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 79 Malaysia Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 80 Malaysia Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 81 Malaysia Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 82 Malaysia Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 83 Malaysia Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 84 Malaysia Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 85 Malaysia Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 86 Rest of Asia Pacific Genomics In Cancer Care Market, 2020 - 2023, USD Million
TABLE 87 Rest of Asia Pacific Genomics In Cancer Care Market, 2024 - 2031, USD Million
TABLE 88 Rest of Asia Pacific Genomics In Cancer Care Market by Application, 2020 - 2023, USD Million
TABLE 89 Rest of Asia Pacific Genomics In Cancer Care Market by Application, 2024 - 2031, USD Million
TABLE 90 Rest of Asia Pacific Genomics In Cancer Care Market by Product, 2020 - 2023, USD Million
TABLE 91 Rest of Asia Pacific Genomics In Cancer Care Market by Product, 2024 - 2031, USD Million
TABLE 92 Rest of Asia Pacific Genomics In Cancer Care Market by Technology, 2020 - 2023, USD Million
TABLE 93 Rest of Asia Pacific Genomics In Cancer Care Market by Technology, 2024 - 2031, USD Million
TABLE 94 key Information – Agilent Technologies, Inc.
TABLE 95 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 96 Key Information – Danaher Corporation
TABLE 97 Key Information – Abbott Laboratories
TABLE 98 Key Information – Bio-Rad Laboratories, Inc.
TABLE 99 Key Information – GE HealthCare Technologies, Inc.
TABLE 100 Key information – Quest Diagnostics Incorporated
TABLE 101 Key Information – Revvity, Inc.
TABLE 102 Key Information – Eurofins Scientific SE
TABLE 103 Key Information – Hologic, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Genomics In Cancer Care Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Genomics In Cancer Care Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2023
FIG 6 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 7 Key Strategic Move: (Mergers and Acquisitions : 2021, Jan – 2023, Jan) Leading Players
FIG 8 Porter’s Five Forces Analysis – Genomics In Cancer Care Market
FIG 9 Asia Pacific Genomics In Cancer Care Market share by Application, 2023
FIG 10 Asia Pacific Genomics In Cancer Care Market share by Application, 2031
FIG 11 Asia Pacific Genomics In Cancer Care Market by Application, 2020 - 2031, USD Million
FIG 12 Asia Pacific Genomics In Cancer Care Market share by Product, 2023
FIG 13 Asia Pacific Genomics In Cancer Care Market share by Product, 2031
FIG 14 Asia Pacific Genomics In Cancer Care Market by Product, 2020 - 2031, USD Million
FIG 15 Asia Pacific Genomics In Cancer Care Market share by Technology, 2023
FIG 16 Asia Pacific Genomics In Cancer Care Market share by Technology, 2031
FIG 17 Asia Pacific Genomics In Cancer Care Market by Technology, 2020 - 2031, USD Million
FIG 18 Asia Pacific Genomics In Cancer Care Market share by Country, 2023
FIG 19 Asia Pacific Genomics In Cancer Care Market share by Country, 2031
FIG 20 Asia Pacific Genomics In Cancer Care Market by Country, 2020 - 2031, USD Million
FIG 21 Swot Analysis: Agilent Technologies, Inc.
FIG 22 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 23 SWOT Analysis: Danaher Corporation
FIG 24 SWOT Analysis: Abbott Laboratories
FIG 25 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 26 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 27 SWOT Analysis: Quest Diagnostics Incorporated
FIG 28 Swot Analysis: Revvity, Inc.
FIG 29 SWOT Analysis: Eurofins Scientific SE
FIG 30 Swot Analysis: Hologic, Inc.